Fast Five Quiz: Alcohol Misuse
Alcohol use disorder remains a significant public health challenge in the United States, affecting more than 29 million individuals and contributing to more than 140,000 deaths each year. Despite its high prevalence and devastating health consequences, alcohol use disorder often goes underdiagnosed and undertreated. A widely accepted heuristic framework conceptualizes alcohol use disorder as a 3-stage cycle, binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation, offering clinicians a lens through which to understand its complex neurobiological underpinnings and diverse clinical presentations.
Although effective behavioral therapies and several US Food and Drug Administration-approved medications are available for the treatment of alcohol use disorder, these interventions remain markedly underused, contributing to a substantial treatment gap.
How much do you know about alcohol misuse and alcohol use disorder? Test your knowledge with this quick quiz.
Medscape © 2025 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Heidi Moawad. Fast Five Quiz: How Much Do You Know About Alcoholism? - Medscape - May 22, 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
19 minutes ago
- Newsweek
What Is Tianeptine? Warning Issued Over 'Gas Station Heroin'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The U.S. Food and Drug Administration (FDA) has stepped up warnings about tianeptine, an unapproved antidepressant increasingly sold in gas stations and convenience stores under names like "Zaza," "Tianna," and "Neptune's Fix." The substance, dubbed "gas station heroin" for its opioid-like effects, is illegal and not approved for medical use in the U.S., although it is legally marketed in some countries as an antidepressant. Why It Matters Tianeptine can be found in some gas stations and convenience stores, often with packaging that mimics legal supplements. Its misuse has drawn increasing attention, particularly due to the way it mimics the effects of opioids, and can cause serious and even fatal side effects. According to the FDA, poison control center cases involving tianeptine exposure causing severe side effects have increased nationwide, from 11 in total between 2000 and 2013 to 151 in 2020 alone. What To Know Despite being illegal, the drug is sometimes illicitly added to foods and beverages or sold as a dietary supplement in the U.S. by some firms. An FDA spokesperson told Newsweek: "The FDA has taken steps to protect people from tianeptine products, including warning consumers that tianeptine is an unsafe food additive." The administration has also issued warning letters to companies distributing and selling unlawful tianeptine products, and issued import alerts to stop tianeptine shipments at the border. A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine. A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine. Uncredited/FDA Office of Regulatory Affairs, Health Fraud Branch via AP What Is Tianeptine? Tianeptine acts on the brain's opioid receptors, which can produce feelings of euphoria at high doses, and the products feature claims—without evidence or FDA approval—that they can help users treat medical conditions, including addiction, pain and depression. "Tianeptine has been used in tens of millions of patients over decades in Europe, Asia and South America and is well documented to be an antidepressant with efficacy roughly similar to first-line antidepressants," Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek. Tianeptine is taken recreationally by some, and has been used to self-treat a variety of ailments, as well as being used chronically. However, abruptly stopping it use can induce withdrawal symptoms similar to those associated with opioids, such as craving, sweating, diarrhea, and others. "Despite this, it has a remarkably safe track record in Europe and the abuse rate when used clinically is extremely low," Javitch said. He also said that used clinically, "there is no immediate perceptible effect on mood," and patients do not experience euphoria. Javitch specializes in experimental therapeutics in psychiatry and is a professor of molecular pharmacology and therapeutics at Columbia. "Doses six times the clinical dose were shown not to produce euphoria, and thus tianeptine works over time through changing brain chemistry and circuitry and synaptic structure," he said. However, he added that taking high doses in "an uncontrolled way is problematic." Javitch stressed that he did not believe products containing tianeptine should be sold in "an uncontrolled way with little oversight over dosing or combination with other medication." According to the FDA, reported adverse effects can include agitation, coma, confusion, death, drowsiness, hypertension, nausea, difficulty breathing, sweating, tachycardia (irregular heartbeat) and vomiting. In 2024, there was a cluster of illnesses in New Jersey associated with the product "Neptune's Fix," which was found to contain tianeptine and synthetic cannabinoid receptor triggers. Adverse effects included tachycardia, seizure and even death. FDA Crackdown The FDA has been taking frequent steps in recent years to warn the public about the dangers of the drug, as well as trying to crack down on companies that include the ingredient in their products. The agency recommends that health care professionals "encourage patients to avoid all products containing tianeptine, including those claiming to treat an ailment or disorder." Instead, the FDA said they should speak to their patients about evidence-based treatment options for opioid use disorder, or cases of depression, anxiety, or pain. States are also taking action independently, and currently a dozen have banned or restricted the sale of tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee. What People Are Saying Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek: "I don't think it should be available at gas stations in an uncontrolled way with little oversight over dosing or combination with other medication. I fear that people will use much higher doses than are clinically indicated, and can escalate dosing and mix with other compounds." He added: "We just have to remember that tianeptine may have major potential as a treatment for depression and anxiety in the right patients, and we are trying to develop a precision psychiatry approach to predicting just which patients will respond to the mediation when used appropriately." Commissioner of Food and Drugs Dr. Martin Makary said in a note last month on the subject: "I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth. "While the FDA is closely following the distribution and sale of these products, it is critical that you appreciate the magnitude of the underlying danger of these products, and disseminate information about it." He added: "Historically, there has been a delayed recognition of fast-growing trends, such as opioid abuse and vaping addiction in youth. Let's be proactive in understanding and addressing the use of tianeptine products, which are available even to our nation's youth." What Happens Next The FDA said it will continue working with local and federal partners to crack down on illegal tianeptine products. It also urged consumers to report any adverse reactions involving tianeptine to the agency's MedWatch program. This article contains reporting by The Associated Press.
Medscape
an hour ago
- Medscape
Hair Experts Report Varying Steroid Techniques for Alopecia
A national survey found broad consensus among hair experts on the use of intralesional corticosteroid (ILC) injections for alopecia but highlighted inconsistencies in dosing and injection parameters. METHODOLOGY: Researchers surveyed 28 dermatologists with hair expertise using a 77-question REDCap survey. Participants averaged 17.7 years of experience, with completion of residency between 1985 and 2022. The response rate was 75% (21 experts completed the survey). The survey assessed ILC injection techniques across alopecia types, including facial alopecia. TAKEAWAY: For nonscarring alopecia, 5 mg/mL was the most common ILC dose (85.7%), followed by 2.5 mg/mL (38.1%); 95.2% of experts injected between 1 and 1.5 mL per session, 95.2% used a 30-gauge needle, and 95.2% injected in a grid pattern. Most experts (71.4%) employed identical ILC techniques for both scarring and nonscarring alopecia, with 61.9% and 60%, respectively, preferring 6-week treatment intervals. The most common ILC dose for scarring alopecia was 5 mg/mL (60%), followed by 7.5 mg/mL (40%) and 10 mg/mL or more (40%). For facial alopecia, 80% of experts used a lower concentration of 2.5 mg/mL, and 90% typically performed 3-4 sessions. For nonscarring alopecia, experts suggested injecting parallel to the direction of hair growth to reduce pain and avoid follicle damage, and for scarring alopecia, they recommended starting with peripheral injections and moving toward the center of the lesion. For facial alopecia, experts recommended shallow injections and avoiding visible vessels to prevent atrophy and bruising. IN PRACTICE: 'Our findings reveal general agreement amongst experts on the use of ILCs for alopecia; however, variation remains in concentration, injection spacing, and treatment duration, especially for facial and scarring alopecia,' the study authors wrote. Although a Delphi study 'could help standardize' ILC treatment approaches, they added, their results 'provide practical guidance for dermatologists on intralesional corticosteroid techniques for the treatment of various alopecia types.' SOURCE: This study was led by Noelle Desir, Department of Dermatology, University of Pennsylvania, Philadelphia, and was published online on June 3 in JAAD International . LIMITATIONS: Limitations included the hair expert identification process and potential response bias in the survey. DISCLOSURES: This study did not receive any funding. One study author reported serving as a consultant, advisory board member, speaker, and investigator for various pharmaceutical and cosmetic companies, including AbbVie, Arcutis Biotherapeutics, Pfizer, and L'Oréal, and also reported receiving royalties from McGraw Hill. Another author reported serving as an advisory board member for Beiersdorf. The remaining authors reported no conflicts of interest.
Yahoo
an hour ago
- Yahoo
We use silly voices with each other – and it makes it hard to have a sex life
My wife and I have been together for seven years. I honestly can't remember the last time we had sex – it's been at least a few years. For most of our relationship, I've taken on the role of caretaker. She struggles with anxiety, was recently diagnosed with attention deficit hyperactivity disorder (ADHD) and often needs a lot of emotional hand-holding. Over time, it's taken a toll on how I see our relationship. We also fell into a habit of using silly, childish voices with each other. What started out as playful has ended up making me feel more like her mother than her wife. For a long time, I didn't have much of a libido, and to her credit, she didn't push the issue. But now that my sex drive has returned, it feels as if it's all I can think about – except I just can't seem to feel that way about her any more. Every time I'm briefly tempted to initiate something, it gets snuffed out by the same patterns: the childish behaviour, the emotional neediness, the feeling of being needed more as a caretaker than a partner. Is it possible to break out of this dynamic? Or have we crossed a line that can't be uncrossed? When one partner becomes a caregiver to the other, the erotic charge between them is very likely to be reduced. And when the childlike element you described creeps into the relationship, a sexual taboo arises. Your feeling of being mother to a child is most definitely not sexy; it connects your psyche with a deep and forbidden sense of incest that is never going to allow you to desire your partner. If you want to desire her again you will have to encourage the adult side of her to be present and engage with you as a competent individual in your lives together. It's possible she may have developed some of the behaviours you dislike as a coping mechanism. If you do not want to spend your life mothering her you must refuse to support the childish behaviour, which is a form of control and passive-aggression. The first step would be to have a frank, adult, non-blaming conversation about the state of your union. Validate the parts of her that are mature and self-reliant, and gently let her know that you would be doing her a disservice to support her learned helplessness any longer. Pamela Stephenson Connolly is a US-based psychotherapist who specialises in treating sexual disorders. If you would like advice from Pamela on sexual matters, send us a brief description of your concerns to (please don't send attachments). Each week, Pamela chooses one problem to answer, which will be published online. She regrets that she cannot enter into personal correspondence. Submissions are subject to our terms and conditions.
